Tajana Stancerić

Publications (3)2.1 Total impact

• Article: Sexual dysfunction in breast cancer survivors.

  Damir Buković, Josip Fajdić, Zlatko Hrgović, Manfred Kaufmann, Iva Hojsak, Tajana Stancerić
  [show abstract] [hide abstract]
  ABSTRACT: The aim of this study was to determine differences in body image and sexuality of breast cancer survivors, depending on treatment: radical mastectomy or breast-conserving surgery. A total of 206 patients treated for breast cancer between January 2001 and January 2004 were asked to fill in the questionnaire 1-5 years after treatment. Patients were divided into 2 groups. The first group consisted of 108 patients with advanced stages of breast cancer and who were treated with modified mastectomy with adjuvant chemo- or radiation therapy. The second group consisted of 98 patients with early stages of breast cancer who were treated with breast conserving surgery, lumpectomy and radiotherapy. A significant number of patients in both groups was satisfied with their sexual life before treatment, 70.37 and 73.47% respectively, which is grossly reduced after treatment of breast cancer (56.48 and 50.00%, respectively, p > 0.05). Most of patients found their partner's attitude towards them to be the same (31.48 and 45.92%), or even better (39.82 and 25.51%) after treatment, and they described them as very supportive and tender. In group 1, 58.33% of patients felt differences in their body image, in contrast to 44.90% in group 2. Similar proportions were observed in both groups for patients who felt mutilated (18.52 vs. 8.16%, p < 0.01). These findings confirm and extend previous reports of impaired sexual functioning among breast cancer survivors.
  Onkologie 01/2005; 28(1):29-34. · 0.87 Impact Factor
• Source

  Available from: srce.hr

  Article: Unilateral multicentric breast cancer.

  Josip Fajdić, Damir Buković, Damir Gugić, Mario Habek, Iva Hojsak, Nevija Buković, Ivan Herman, Tajana Stancerić
  [show abstract] [hide abstract]
  ABSTRACT: Clinical characteristics of unilateral multicentric breast cancer (UMBC) were explored depending on aggressiveness, survival rate, disease-free period and local recurrence. The study included 296 women with breast cancer, surgically treated between 1990 and 2001. UMBC was histologically proved in 29 (9.8%) patients. Multicentricity was defined by following criteria: a) tumor with minimum one satellite node in the same or other quadrant of the breast; b) minimum one cut through the breast without tumor cells; c) histopathologically, discontinued tumors with intra-ductal invasion. The average age of patients was 63.4 (range 36-85). There were 9 (31.0%) women with one satellite node, 7 (24.1%) women with two satellite nodes, and 13 (44.8%) women with three or more satellite nodes. At the operation, axilla was positive in 20 (68.9%) women. Steroid receptors were highly positive in 12 (41.4%) patients. Primary and secondary tumors were of the same histological type in 26 (89.6%) patients. Local recurrence was found in only 3 (10.3%) patients. A five-year period without disease was achieved in 24 (82.7%) women. Kaplan-Meier analysis showed a significantly higher survival rate at lower tumor stages (I or II) unlike in advanced stages with predominantly N2 grade. The results of this study showed a slightly lower five-year disease-free period than in the case of patients with monocentric breast cancer (MOBC). The survival rate was significantly lower at all advanced stages, especially determined by N2 axilla. Therefore, the conclusion is that multicentricity doesn't increase the risk of poor prognosis, especially at lower tumor stages.
  Collegium antropologicum 01/2004; 27(2):693-8. · 0.61 Impact Factor
• Source

  Available from: srce.hr

  Article: Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure.

  Slaven Kokić, Damir Buković, Maja Radman, Vesna Capkun, Nikica Gabrić, Vesna Lesko, Deni Karelović, Tajana Stancerić
  [show abstract] [hide abstract]
  ABSTRACT: The purpose of the study was to find out differences between treatments of diabetes type 2 after secondary oral antidiabetic drug failure. Three different methods of treatment were compared: lispro insulin in combination with metformin, glimepiride and metformin combination or two daily doses of biphasic insulin 30/70 together with bed-time NPH insulin. The study included 87 patients with diabetes mellitus type 2 randomly distributed into 3 different treatment groups. Fasting and postprandial glucose were analyzed by enzymatic colorimetric method and HbA1c was measured by ion exchange chromatography. HbA1c significantly decreased in all three study groups. The decrease was mostly expressed among patients treated with lispro and metformin. When focused on postprandial glucose control, antihyperglycemic metformin and insulin lispro therapy has greater impact on the overall metabolic control (decrease in level of HbA1c) in comparison with the above mentioned more traditional approaches.
  Collegium antropologicum 07/2003; 27(1):181-7. · 0.61 Impact Factor